John M. Maraganore
Overview
John M. Maraganore received an average of $4M in total compensation, including $691K in salary, at Alnylam Pharmaceuticals from 2007 to 2021.
2021Alnylam PharmaceuticalsFormer Chief Executive Officer (principal executive officer
2020Alnylam PharmaceuticalsChief Executive Officer (principal executive officer
2019Alnylam PharmaceuticalsChief Executive Officer (principal executive officer
2018Alnylam PharmaceuticalsChief Executive Officer (principal executive officer
2017Alnylam PharmaceuticalsChief Executive Officer principal executive officer
2016Alnylam PharmaceuticalsChief Executive Officer principal executive officer
2015Alnylam PharmaceuticalsChief Executive Officer principal executive officer
2014Alnylam PharmaceuticalsChief Executive Officer principal executive officer
2013Alnylam PharmaceuticalsChief Executive Officer principal executive officer
2012Alnylam PharmaceuticalsChief Executive Officer principal executive officer
Source: SEC filings on April 5, 2022, April 2, 2021, March 23, 2018, March 17, 2016, March 10, 2015, April 29, 2014, May 2, 2011, and April 20, 2010.
Related executives
We found 13 more executives who work or worked at Alnylam Pharmaceuticals.
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
Tolga Tanguler
Alnylam Pharmaceuticals
Executive Vice President, Chief Commercial Officer
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
Barry Greene
Alnylam Pharmaceuticals
Former President
Laurie Keating
Alnylam Pharmaceuticals
Chief Legal Officer
Manmeet Soni
Alnylam Pharmaceuticals
Chief Financial Officer
Michael Mason
Alnylam Pharmaceuticals